-transparent.png){kind=logo}
Interleukin 12 (IL12, NKSF-natural killer stimulatory factor) was found to stimulate natural killer (NK) cell activity of hairy cell leukemia (HCL) patients. Two patients not responding to IL12 stimulation were also resistant to interferon alpha (IFN alpha)-mediated augmentation of NK activity. IL12 also enhanced slightly the interleukin 2 (IL2)-induced cytotoxicity of HCL patients, while IFN alpha reduced the stimulatory effect of IL2. These data suggest that interleukin 12 has NK modulatory properties in HCL leukemia patients, which may be different from those of IFN alpha.
Related Publications
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
January 1996,
Cancer immunology, immunotherapy : CII,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
January 1990,
Annales de recherches veterinaires. Annals of veterinary research,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
May 1981,
Nature,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
August 1993,
Cancer research,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
June 1996,
Journal of leukocyte biology,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
January 1988,
Annals of the New York Academy of Sciences,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
June 2012,
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
January 1983,
Clinical immunology and immunopathology,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
March 1986,
Cancer,
J Bigda, and
J Mysliwska, and
R Dziadziuszko, and
J Bigda, and
A Mysliwski, and
A Hellmann
March 2005,
Experimental hematology,
